127 related articles for article (PubMed ID: 7023187)
1. Cell-associated immunoglobulin in human non-Hodgkin lymphomas. A comparative study of surface immunoglobulin on cells in suspension and cytoplasmic immunoglobulin by immunohistochemistry.
Landaas TO; Godal T; Marton PF; Kvaløy S; Langholm R; Lindmo T; Jørgensen OG; Høst H
Acta Pathol Microbiol Scand A; 1981 Mar; 89(2):91-101. PubMed ID: 7023187
[TBL] [Abstract][Full Text] [Related]
2. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
3. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
4. Immunological subsets in human B-cell lymphomas.
Godal T; Lindmo T; Marton PF; Landaas TO; Langholm R; Høie J; Foss Abrahamsen A
Scand J Immunol; 1981 Nov; 14(5):481-92. PubMed ID: 6977823
[TBL] [Abstract][Full Text] [Related]
5. Correlations between immunological phenotype and karyotype in malignant lymphoma.
Levine EG; Arthur DC; Gajl-Peczalska KJ; LeBien TW; Peterson BA; Hurd DD; Bloomfield CD
Cancer Res; 1986 Dec; 46(12 Pt 1):6481-8. PubMed ID: 3096564
[TBL] [Abstract][Full Text] [Related]
6. Identification of two major B cell forms of nodular mixed lymphoma.
Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
[TBL] [Abstract][Full Text] [Related]
7. [Malignant centroblastic and immunoblastic lymphoma. Results of a direct immunofluorescence study of 43 samples after inclusion in paraffin].
Audouin J; Diebold J
Pathol Biol (Paris); 1984 Jun; 32(6):679-87. PubMed ID: 6431384
[TBL] [Abstract][Full Text] [Related]
8. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
Lauder I; Bird CC; Child JA; Grigor I
J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
[TBL] [Abstract][Full Text] [Related]
9. Primary gastrointestinal malignant lymphomas. A morphologic and immunohistochemical study.
Papadimitriou CS; Papacharalampous NX; Kittas C
Cancer; 1985 Feb; 55(4):870-9. PubMed ID: 3917844
[TBL] [Abstract][Full Text] [Related]
10. Detection of J chain in lymphomas and related disorders.
Laurent G; Delsol G; Reyes F; Abbal M; Mihaesco E
Clin Exp Immunol; 1981 Jun; 44(3):620-8. PubMed ID: 6799238
[TBL] [Abstract][Full Text] [Related]
11. Lack of surface immunoglobulin light chain expression by flow cytometric immunophenotyping can help diagnose peripheral B-cell lymphoma.
Li S; Eshleman JR; Borowitz MJ
Am J Clin Pathol; 2002 Aug; 118(2):229-34. PubMed ID: 12162683
[TBL] [Abstract][Full Text] [Related]
12. Immune marker expression in 53 lymphomas of high-grade malignancy.
Pallesen G; Madsen M; Schifter S
Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
[TBL] [Abstract][Full Text] [Related]
13. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
15. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
Meusers P; Brittinger G
Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
[TBL] [Abstract][Full Text] [Related]
16. Lack of expression of surface immunoglobulin light chains in B-cell non-Hodgkin lymphomas.
Kaleem Z; Zehnbauer BA; White G; Zutter MM
Am J Clin Pathol; 2000 Mar; 113(3):399-405. PubMed ID: 10705821
[TBL] [Abstract][Full Text] [Related]
17. Immunologic subsets in B cell lymphomas defined by surface immunoglobulin isotype and complement receptor--their relationship to survival.
Kvaløy S; Langholm R; Kaalhus O; Marton PF; Høst H; Godal T
Scand J Haematol; 1985 Aug; 35(2):137-44. PubMed ID: 3876595
[TBL] [Abstract][Full Text] [Related]
18. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas.
Williamson JM; Grigor I; Smith ME; Holgate CS; Quirke P; Bird CC; Alison DL; Child JA
J Pathol; 1986 Sep; 150(1):51-9. PubMed ID: 3491205
[TBL] [Abstract][Full Text] [Related]
19. Clonality assessment of lymphoproliferative disorders by multiparameter flow cytometry of paraffin-embedded tissue: an additional diagnostic tool in surgical pathology.
Leers MP; Theunissen PH; Ramaekers FC; Schutte B; Nap M
Hum Pathol; 2000 Apr; 31(4):422-7. PubMed ID: 10821487
[TBL] [Abstract][Full Text] [Related]
20. Analysis and detection of B cell neoplasms.
Frenkel EP; Smith RG; Ligler FS; Hernandez J; Himes JB; Sheehan RG; Vitetta ES; Kettman JR; Uhr JW
Blood Cells; 1980; 6(4):783-98. PubMed ID: 6781556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
